
Thanks to successful negotiation of a managed access agreement, NICE has announced its recommendation of Bristol-Myers Squibb’s Opdivo (nivolumab) for …

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.

A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …

Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the …

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …

Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …

An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …

The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …

In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …

A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …

Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …